$CCNE

CNB FINANCIAL CORP/PA (CCNE): Results of Operations and Financial Condition

CNB FINANCIAL CORP/PA (CCNE) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ccne7-23x2699x1.htm EX-99.1 Document News Release Contact: Tito L. Lima Treasurer (814) 765-9621 FOR IMMEDIATE RELEASE CNB FINANCIAL CORPORATION REPORTS SECOND QUARTER 2026 RESULTS Clearfield, Pennsylvania – July 23, 2026 CNB Financial Corporation (“Corporation”) (NASDA

Original reporting
Published Jul 23, 2026, 8:13 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 23, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$CCNE
Bullish
medium confidence
Mentioned
$CCNE
Relevance
7/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$CCNEBullishMed
01

Why it matters

Sequential improvement in earnings and net interest margin, alongside organic loan growth, may support valuation, but deposit softness (including held-for-sale and a higher-cost deposit exit) and higher nonperforming assets are key counterweights.

02

Market read

Fresh quarterly datapoints on earnings, NIM, loans, deposits, and credit quality can drive near-term repricing for CCNE and inform expectations for subsequent quarters.

03

What to watch

The release highlights a municipal deposit exit and purchase accounting accretion in NIM; traders may want to separate core trends from one-off items and acquisition-related effects.

Relevance 7/10Novelty 7/10Timing: after-hours, following the Q2 2026 earnings release in an 8-K

Background

This is CNB Financial Corporation’s SEC 8-K with an attached earnings release for the three and six months ended June 30, 2026.

Company-level read

Ticker impact

$CCNEBullishMedium confidence
Context

CNB Financial reported Q2 2026 results, including net income of $27.2M ($0.91/diluted) and net interest margin rising to 3.88%.

Expected impact

Moderately positive near-term bias if investors view NIM improvement and loan growth as offsetting deposit softness and higher nonperforming assets.

Evidence & confidence

The filing is a primary earnings release with multiple quantified drivers: earnings up vs prior quarter, NIM up, organic loans up, and credit quality deterioration limited to one C&I relationship.

Market effects

Regional bank read-through on net interest margin resilience and deposit beta, plus credit-quality monitoring via nonperforming assets and charge-offs.

Potential sentiment spillover to other Pennsylvania and Mid-Atlantic community banks tracking similar funding and credit conditions.

Limited; primarily affects US regional banking sentiment and rate-sensitive earnings expectations.

Counterpoint

Deposit decline and rising nonperforming assets could outweigh the NIM uptick, especially if the higher NPA level signals emerging credit stress.

Key entities

  • CNB Financial Corporation

    Parent company of CNB Bank, reporting Q2 2026 results and balance-sheet metrics in an 8-K.

  • CNB Bank

    Operating bank referenced as the entity behind the parent’s reported financial condition.

  • ESSA Bancorp, Inc.

    Referenced for merger and integration costs and acquisition-related impacts on earnings and loan growth.

Related articles

$DLXMed

Deluxe Q2 Earnings Call Highlights

Deluxe (NYSE:DLX) reported Q2 segment results, led by Data Solutions revenue up 21.4% to $82.3M and adjusted EBITDA of $18.1M. Merchant Services revenue rose 6.1% to $107.6M. Print revenue fell 4.3% to $235.9M. Deluxe closed its Celero acquisition on July 31 and raised 2026 guidance: revenue $2.095B-$2.12B, adj. EBITDA $455M-$475M, adj. EPS $3.60-$4.00, and FCF about $200M.

$NEOGMedAI 8/10

Neogen (NEOG) Q4 2026 Earnings Call Transcript

Neogen (NEOG) reported fiscal Q4 2026 revenue of $225.3 million, up 4.3% in core growth, led by Food Safety. Adjusted gross margin rose to 49.7% and adjusted EBITDA grew 12% to $45.4 million. FY2027 guidance: revenue $880-$885 million and adjusted EBITDA $180-$182 million. The company plans a 50% R&D increase and a $140 million genomics divestiture for debt reduction.

$FTSMed

Fortis (FTS) Q2 2026 Earnings Call Transcript

Fortis (FTS) reported Q2 2026 net earnings of C$396 million, up C$26 million year over year, and EPS of C$0.78. Capital expenditures were C$2.7 billion through June, with a C$5.6 billion 2026 plan. Management reiterated 4% to 6% dividend growth through 2030 and cited Tilbury LNG Phase 1B approval and a 9.75% ROE request in an Arizona rate case.

$ANMed

AutoNation (AN) Q2 2026 Earnings Call Transcript

AutoNation (AN) reported Q2 2026 adjusted diluted EPS of $5.56, up 2% year over year, with total revenue of $6.93 billion, essentially flat. After-sales gross profit was a record $607 million, and Customer Financial Services profitability rose to $2,800 per vehicle. ANF net income increased to $11 million and the portfolio grew to $2.67 billion. The company repurchased $457 million of shares and acquired four stores.

$DOCMed

Healthpeak Properties Q2 Earnings Call Highlights

Healthpeak Properties (NYSE:DOC) highlighted Q2 results and updates on capital recycling and leasing. It recapitalized a Brookfield outpatient portfolio, retaining 51% interest and raising $1B cash, and noted a 5.9% trailing cash cap rate. Lab occupancy rose to 78.5%. Net debt/adj. EBITDA was 4.7x with $4.1B liquidity; it repaid $900M debt and repurchased $100M shares.

$MTDHighAI 9/10

Mettler-Toledo (MTD) Q2 2026 Earnings Call Transcript

Mettler-Toledo (MTD) reported Q2 2026 net sales of $1.027B, up 4% reported (6% local currency). Adjusted EPS was $11.46, up 14%. Adjusted operating margin was 29.3%. The company raised full-year 2026 guidance to 4% to 5% local currency revenue growth and adjusted EPS of $47.15 to $47.50, and plans $875M share repurchases.